TipRanks
Corvus Pharmaceuticals Inc (DE:C17)
FRANKFURT:C17
Germany Market

Corvus Pharmaceuticals (C17) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Corvus Pharmaceuticals Inc’s (C17) Moving Averages Convergence Divergence (MACD) indicator is -0.69, suggesting Corvus Pharmaceuticals Inc is a Buy.
Corvus Pharmaceuticals Inc’s (C17) 20-Day exponential moving average is 9.79, while Corvus Pharmaceuticals Inc’s (C17) share price is €12.24, making it a Sell.
Corvus Pharmaceuticals Inc’s (C17) 50-Day exponential moving average is 10.67, while Corvus Pharmaceuticals Inc’s (C17) share price is €12.24, making it a Sell.

Corvus Pharmaceuticals (C17) Pivot Points

Oct 14, 2026, 11:28 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.02
9.02
9.02
9.02
9.02
9.02
9.02
Fibonacci
9.02
9.02
9.02
9.02
9.02
9.02
9.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Corvus Pharmaceuticals (C17) Moving Averages

Oct 14, 2026, 11:28 PM
Period
Simple
Exponential
MA5
8.89Sell
8.91Sell
MA10
9.26Sell
9.23Sell
MA20
9.91Sell
9.79Sell
MA50
11.12Sell
10.67Sell
MA100
11.25Sell
11.08Sell
MA200
12.11Sell
10.95Sell
Corvus Pharmaceuticals Inc’s (C17) 10-Day exponential moving average is 9.23, while Corvus Pharmaceuticals Inc’s (C17) share price is €12.24, making it a Sell.
Corvus Pharmaceuticals Inc’s (C17) 100-Day exponential moving average is 11.08, while Corvus Pharmaceuticals Inc’s (C17) share price is €12.24, making it a Sell.
Corvus Pharmaceuticals Inc’s (C17) stock price is €12.24 and Corvus Pharmaceuticals Inc’s (C17) 50-day simple moving average is 11.12, creating a Sell signal.
Corvus Pharmaceuticals Inc’s (C17) stock price is €12.24 and Corvus Pharmaceuticals Inc’s (C17) 100-day simple moving average is 11.25, creating a Sell signal.
Corvus Pharmaceuticals Inc’s (C17) stock price is €12.24 and Corvus Pharmaceuticals Inc’s (C17) 200-day simple moving average is 12.11, creating a Sell signal.

Corvus Pharmaceuticals (C17) Technical Indicators

Oct 14, 2026, 11:28 PM
Name
Value
Implied Action
RSI (14)
30.45
Neutral
STOCH (9,6)
8.11
Buy
STOCHRSI (14)
4.17
Buy
MACD (12,26)
-0.69
Buy
ADX (14)
21.46
Neutral
Williams %R
-99.29
Buy
CCI (14)
-123.03
Buy
ATR (14)
0.34
-
Ultimate Oscillator
32.90
Neutral
ROC
-20.24
Sell
Corvus Pharmaceuticals Inc’s (C17) Relative Strength Index (RSI) is 30.45, creating a Neutral signal.
Corvus Pharmaceuticals Inc’s (C17) Trend Strength Indicator (ADX) is 21.46, creating a Neutral signal.
Corvus Pharmaceuticals Inc’s (C17) Commodity Channel Index (CCI) is -123.03, creating a Buy signal.
Corvus Pharmaceuticals Inc’s (C17) Price Rate of Change (ROC) is -20.24, creating a Sell signal.

FAQ

Is C17 a Buy, Hold, or Sell?
Based on C17’s technical indicators, C17 is a Sell.
    What is C17’s RSI (14)?
    C17’s RSI (14) is 30.45, which suggests C17 is a Neutral.
      What is C17’s MACD?
      C17’s MACD is -0.69, which suggests C17 is a Buy.
        What is C17’s 5-day moving average?
        C17’s 5-day moving average is 8.89, which suggests C17 is a Sell.
          What is C17’s 20-day moving average?
          C17 20-day moving average is 9.91, which suggests C17 is a Sell.
            What is C17’s 50-day moving average?
            C17’s 50-day moving average is 11.12, which suggests C17 is a Sell.
              What is C17’s 200-day moving average?
              C17’s 200-day moving average is 12.11, which suggests C17 is a Sell.
                What is C17’s Williams % R (14)?
                C17’s Williams % R (14) is -99.29, which suggests C17 is a Buy.
                  What is C17’s CCI (14)?
                  C17’s CCI (14) is -123.03, which suggests C17 is a Buy.
                    What is the share price of Corvus Pharmaceuticals Inc?